Midazolam: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Midazolam. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Overall | 40% |
| Hypoxia | 9% |
| Agitated | 6% |
| Respiratory depression | 5% |
| Rhonchi | 5% |
| Airway obstruction | 4% |
| Upper airway congestion | 4% |
| Bradycardia | 4% |
| Emesis | 3% |
| Nausea | 2% |
| Bigeminy | 2% |
| Prolonged sedation | 2% |
| Rash | 2% |
| Laryngospasm | 1% |
| Sneezing/ rhinorrhea | 1% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Midazolam HCl syrup is indicated for use in pediatric patients for sedation, anxiolysis and amnesia prior to diagnostic, therapeutic or endoscopic procedures or before induction of anesthesia. Midazolam HCl syrup is intended for use in monitored settings only and not for chronic or home use [see WARNINGS ].
Source: FDA labeling via NIH DailyMed (set 9a443652…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.